Welch Group’s GSK GSK Stock Holding History

Welch Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,618	Closed	-$108K	–	141
2014 Q2	$108K	Buy	1,618 +104	+7%	+$7.04K	0.02%	139
2014 Q1	$101K	Hold	1,514	–	–	0.02%	124
2013 Q4	$101K	Buy	+1,514	New	+$98.2K	0.02%	128

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Welch Group's GSK Position: Q3 2014 in Review

Welch Group sold out of GSK (GSK) in Q3 2014, closing a stake of 1,618 shares — an estimated $108K sold.

Welch Group first reported a position in GSK in Q4 2013 and held it in 3 quarters. The position peaked at $108K in Q2 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

Welch Group reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
Welch Group sold 1,618 GSK shares in Q3 2014, an estimated $108K.
Welch Group first reported a position in GSK in Q4 2013 and held it in 3 quarters.
Welch Group's GSK position peaked at $108K in Q2 2014.
701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Welch Group's 13F filing for Q3 2014, filed 29 Oct 2014.